| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |